16 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Clinical Characteristics and Prognosis of Biliary Atresia with Low Serum Matrix Metalloproteinase-7 Levels

Video Published 2024-07-23 Updated 2026-08-01

Timestops (2)

0:00
Do you take matrix metaloproteina7 in patients with biliary …
Do you take matrix metaloproteina7 in patients with biliary atresia? Hi, I'm Cecilia Jigenna from Cincinnati Children's …
0:27
And what they found is that these patients had significantly…
And what they found is that these patients had significantly lower 3 month and 6 month jaundice clearance and significan…

Topic Overview

A retrospective cohort study from China examined 329 biliary atresia patients, identifying 40 with low serum matrix metalloproteinase-7 (MMP-7) levels. These patients demonstrated significantly lower jaundice clearance rates at 3 and 6 months post-intervention and reduced 1-year native liver survival compared to those with normal MMP-7. The findings suggest MMP-7 measurement may serve as a prognostic biomarker in biliary atresia management.

Key Takeaways

  • Low serum MMP-7 in biliary atresia patients correlates with worse jaundice clearance at 3 and 6 months post-Kasai procedure.
  • Patients with low MMP-7 had significantly lower 1-year native liver survival compared to those with normal levels.
  • MMP-7 measurement may serve as a prognostic biomarker to stratify biliary atresia patients for closer monitoring or intervention.
  • Study cohort: 329 biliary atresia patients in China, 40 (12%) had low MMP-7 levels at diagnosis.
  • Future research may explore MMP-7-targeted therapies to improve outcomes in this high-risk subgroup.

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Cecilia Jigenna — host

Chapters

  • 0:00MMP-7 as a Prognostic Marker in Biliary Atresia — Introduction to a Chinese retrospective cohort study examining the clinical characteristics and outcomes of biliary atresia patients with low serum MMP-7 levels, including findings on jaundice clearance and native liver survival.

Key claims

  • 0:11The study was a retrospective cohort study conducted in China — Cecilia Jigenna
  • 0:21The study included 329 patients with biliary atresia — Cecilia Jigenna
  • 0:2140 of the 329 patients had low MMP-7 levels — Cecilia Jigenna
  • 0:27Patients with low MMP-7 had significantly lower 3-month jaundice clearance — Cecilia Jigenna
  • 0:27Patients with low MMP-7 had significantly lower 6-month jaundice clearance — Cecilia Jigenna
  • 0:27Patients with low MMP-7 had significantly lower 1-year native liver survival — Cecilia Jigenna
  • 0:40Measuring MMP-7 can help with prognosis in biliary atresia patients — Cecilia Jigenna
  • 0:40MMP-7 measurement may in the future help with treatment of biliary atresia patients — Cecilia Jigenna

Open questions

  • How might MMP-7 measurement guide treatment decisions in biliary atresia management?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Keywords

biliary atresia jaundice Cincinnati Children's Hospital

Hashtags

#biliaryatresia #MMP7 #jaundice #liversurvival #prognosis #pediatricgastroenterology #PediatricHepatology #MMP7Biomarker #LiverSurgery

Transcript

Comments

Loading comments…